Dis-Chem co-founder Ivan Saltzman has resigned from the pharmacy retailer’s board after 48 years. His departure ends the founding family’s formal representation in the company’s boardroom. The JSE-listed healthcare group said Saltzman stepped down as a non-executive director with effect from 23 July 2026. He retired as an executive director at the end of June. He then briefly served in…
Tag: Corporate Governance
-
Private Healthcare Market Dominance Reveals Serious Problems
A new report reveals a troubling reality. A small group of private hospitals and medical schemes are earning huge profits. This is due to their ongoing market dominance. The advocacy group Open Secrets states that a lack of regulation is a key factor in this issue. Six years ago, the Competition Commission raised similar concerns. However, very little has changed…
-
Bidvest’s Role in Adcock Ingram Takeover Bid
In a striking case of corporate déjà vu, South African pharmaceutical firm Adcock Ingram is once again the subject of a foreign takeover bid. However, the script has been flipped. Bidvest, the conglomerate that positioned itself as the company’s patriotic saviour over a decade ago, is now orchestrating its sale to an overseas partner. This culminates in a patient power…